We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
-6.85%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$10.1M
Cap. Flow
+$2.31M
Cap. Flow %
2.12%
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10

Top Buys

1
CVS icon
CVS Health
CVS
+$1.88M
2
ARKO icon
ARKO Corp
ARKO
+$1.61M
3
BIDU icon
Baidu
BIDU
+$1.51M
4
THFF icon
First Financial Corp
THFF
+$955K
5
TALO icon
Talos Energy
TALO
+$935K

Top Sells

1
AMSC icon
American Superconductor
AMSC
+$3.38M
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$2.96M
3
INCY icon
Incyte
INCY
+$1.71M
4
FHN icon
First Horizon
FHN
+$1.54M
5
TRC icon
Tejon Ranch
TRC
+$693K

Sector Composition

1 Healthcare 35.69%
2 Technology 11.09%
3 Materials 10.64%
4 Consumer Staples 8.17%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
51
DELISTED
Verona Pharma
VRNA
$506K 0.46%
35,000
– –
FEMY icon
52
Femasys
FEMY
$9.21M
$485K 0.44%
21,250
+1,250
+6% +$31.9K
BATL icon
53
Battalion Oil
BATL
$34.6M
$468K 0.43%
140,000
+10,000
+8% +$53.4K
ASRT
54
DELISTED
Assertio
ASRT
$434K 0.4%
23,333
+333
+1% +$4.95K
ELDN icon
55
Eledon Pharmaceuticals
ELDN
$296M
$422K 0.39%
160,000
– –
EDSA icon
56
Edesa Biotech
EDSA
$64.7M
$385K 0.35%
90,000
+28,000
+45% +$125K
LTRN icon
57
Lantern Pharma
LTRN
$37.1M
$374K 0.34%
80,000
+15,000
+23% +$90.2K
CGTX icon
58
Cognition Therapeutics
CGTX
$84.1M
$332K 0.3%
200,000
+25,000
+14% +$49.8K
CMPX icon
59
Compass Therapeutics
CMPX
$378M
$310K 0.28%
310,000
– –
CADE
60
DELISTED
Cadence Bank
CADE
$283K 0.26%
10,000
– –
ELTX icon
61
Elicio Therapeutics
ELTX
$84M
$206K 0.19%
50,000
-25,000
-33% -$211K
KRON
62
DELISTED
Kronos Bio
KRON
$167K 0.15%
135,000
-115,000
-46% -$117K
GANX icon
63
Gain Therapeutics
GANX
$70.8M
$115K 0.11%
90,000
– –
AMSC icon
64
American Superconductor
AMSC
$1.6B
– –
-250,000
Closed -$3.38M
BCDA icon
65
BioCardia
BCDA
$12.7M
– –
-46,667
Closed -$285K
FHN icon
66
First Horizon
FHN
$12.1B
– –
-100,000
Closed -$1.54M
INCY icon
67
Incyte
INCY
$23.3B
– –
-30,000
Closed -$1.71M
RIGL icon
68
Rigel Pharmaceuticals
RIGL
$771M
– –
-200,000
Closed -$2.96M
RNAC icon
69
Cartesian Therapeutics
RNAC
$245M
– –
-10,183
Closed -$199K
SMSI icon
70
Smith Micro Software
SMSI
$14.4M
– –
-15,000
Closed -$207K
TRC icon
71
Tejon Ranch
TRC
$504M
– –
-45,000
Closed -$693K
VTOL icon
72
Bristow Group
VTOL
$1.31B
– –
-15,377
Closed -$418K
PVLA
73
Palvella Therapeutics
PVLA
$2.12B
– –
-7,188
Closed -$105K
1 2
3

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q2 2024 Portfolio in Review

As of Q2 2024, CM Management held 73 positions worth $109M, down 8.5% from $119M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CM Management's Q2 2024 filing shows 4 new, 25 increased, 5 reduced and 10 closed positions. Its largest new stake was CVS Health: 30,000 shares worth $1.77M. The largest sale was American Superconductor, an estimated $3.38M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 43% a quarter earlier, followed by Technology and Materials.

  • CM Management's largest Q2 2024 buy was CVS Health: 30,000 shares worth $1.77M.
  • CM Management added most to ARKO Corp in Q2 2024, an estimated $1.61M increase.
  • CM Management's biggest Q2 2024 reduction was Pan American Silver, cutting an estimated $493K.
  • CM Management fully exited American Superconductor in Q2 2024, selling an estimated $3.38M.
  • CM Management's ten largest holdings make up 38% of its $109M portfolio in Q2 2024.
  • CM Management opened 4 new positions and closed 10 in Q2 2024.
  • CM Management's portfolio value fell 8.5% quarter-over-quarter to $109M.

Based on CM Management's 13F filing for Q2 2024, filed 1 Aug 2024.